A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

NCT00505037 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperphosphatemia
Chronic Kidney Disease

Interventions

DRUG: ASP1585
DRUG: Placebo
DRUG: Sevelamer hydrochloride

Sponsor

Astellas Pharma Inc